NasdaqGS:RPRXPharmaceuticals
What Recent Royalty Deals Mean for Royalty Pharma Shares After a 56.7% Rally in 2025
Curious whether Royalty Pharma is trading at a bargain, or if its recent performance signals something more? You are not alone. Valuation-focused investors have been eyeing this stock closely.
After a strong run, Royalty Pharma’s shares are up 10.2% in the last week and 11.9% this month, racking up an impressive 56.7% gain year-to-date.
Recent headlines have highlighted Royalty Pharma's aggressive moves in acquiring new royalty interests and expanding its biopharma portfolio. Both of these...